Results 1 to 10 of about 2,197,987 (237)
This rare type of acute leukemia, blast cells of which express myeloid and/or lymphoid markers, is mainly diagnosed using flow cytometric findings. The paper describes a clinical case of mixed-phenotype acute leukemia, in which B-cell lymphoid antigen ...
S V Gritsaev +9 more
doaj
Significance of Inactivated Genes in Leukemia: Pathogenesis and Prognosis
Epigenetic and genetic alterations are two mechanisms participating in leukemia, which can inactivate genes involved in leukemia pathogenesis or progression.
Nazanin Heidari +5 more
doaj +1 more source
Recurrent deletions of IKZF1 in pediatric acute myeloid leukemia
IKAROS family zinc finger 1/IKZF1 is a transcription factor important in lymphoid differentiation, and a known tumor suppressor in acute lymphoid leukemia. Recent studies suggest that IKZF1 is also involved in myeloid differentiation.
Jasmijn D.E. de Rooij +12 more
doaj +1 more source
Mixed phenotype acute leukemia (MPAL) is a rare leukemia that presents both myeloid and lymphoid markers on blasts. Here the authors perform genomic analysis to show MPAL involves genetic and epigenetic heterogeneity and is genetically distinct from AML,
Koichi Takahashi +29 more
doaj +1 more source
Among 4,780 consecutive adult acute lymphoblastic/myeloblastic leukemia patients, we identified 117 (2.4%) patients with mixed-phenotype acute leukemia fulfilling WHO 2008 criteria; these were classified as: Blymphoid+ myeloid (n=64), T-lymphoid+myeloid (
Lingzhi Yan +9 more
doaj +1 more source
Prognostic relevance of RUNX1 mutations in T-cell acute lymphoblastic leukemia
The runt-related transcription factor 1, RUNX1, is crucial in the development of myeloid and lymphoid cell lineages and has been reported to be mutated in myeloid malignancies in approximately 30% of cases.
Vera Grossmann +8 more
doaj +1 more source
Outcome of biphenotypic acute leukemia
BACKGROUND AND OBJECTIVE: Although biphenotypic leukemia is now a defined entity, outcome of this rare form of acute leukemia has not been well documented.
S Killick +8 more
doaj
Background Treatment of acute leukemia is challenging and long-lasting remissions are difficult to induce. Innovative therapy approaches aim to complement standard chemotherapy to improve drug efficacy and decrease toxicity.
Theresa Lowinus +10 more
doaj +1 more source
5q deletion in childhood T-acute lymphoblastic leukemia at diagnosis: a case report
Background We present the case of a 6-year-old Moroccan male patient of Berber ethnic origin, diagnosed with T-cell acute lymphoblastic leukemia, who exhibited a deletion of the 5q region.
Yousra Sbibih +6 more
doaj +1 more source
Acute lymphoblastic leukemia in the elderly. A twelve-year retrospective, single center study
Acute myeloid leukemia in elderly patients is a well-studied disease, while only a few studies on acute lymphoid leukemia (ALL) in elderly patients have been reported and their results are not encouraging. The aims of the present study were to review the
L Pagano +5 more
doaj

